COVID-19 has shed light on the high dependence of Latin America and the Caribbean on imports of health technologies from outside the Region and the vulnerability of global supply. PAHO its Member States and regional partners have renewed the efforts to improve local production capacities in the region and, at the request of Member States, PAHO launched a collaborative Platform that convene public and private stakeholders to facilitate the expansion of vaccine and other health technology research, development, and manufacturing in the Region.
Objective and goal
Generate a space for discussion and exchange of experiences to identify of opportunities for regional cooperation to increase the production capacities of medicines and other essential health technologies, including vaccines, to contribute to equitable access to these products.
The platform will foster research and incentivize the development and manufacturing of essential and strategic health technologies in the Americas, expanding manufacturing capacities to ensure access to safe, effective, and quality products, facilitating information exchange and foster cooperation between partners and countries.
The goal is to take advantage of existing production capacities that could contribute to manufacturing mRNA vaccines in the Americas. The principle is that manufacturing should benefit the entire region, with regional pharmaceutical production and distribution of the vaccines by PAHO’s Revolving Fund to all countries.